


D&E Research - Datos & Estrategias
Research Services • Bal Harbour, Florida, United States • 1-10 Employees
Company overview
| Headquarters | 10150 Collins Ave, 201, Miami Beach, Florida 33154, US |
| Website | |
| NAICS | 5417 |
| Keywords | Recruitment, Business Intelligence, Compliance, Rare Diseases, Oncology, Fieldwork, Data Processing, Market Access, Advanced Analytics, Observational Studies, Pharma Research, Patient Diaries, Online Methodologies, Latam Coverage, Compliance And Quality, Geographical Spread Samples, Healthcare System Network, High Quality Interviewers, Influence Network In Healthcare, Innovative Customized Research Designs, Long Experience In Therapeutical Areas, Qualitative And Quantitative, Web Assisted Tdis |
| Founded | 1985 |
| Employees | 1-10 |
| Socials |
Key Contact at D&E Research - Datos & Estrategias
Stella Carullo
Founder and President
D&E Research - Datos & Estrategias Email Formats
D&E Research - Datos & Estrategias uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@deresearch-latam.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@deresearch-latam.com | 100% |
About D&E Research - Datos & Estrategias
D&E is a marketing consulting agency founded in 1985, that operates US & whole LATAM region. Qualitative and quantitative research projects at a pan regional level. Therapeutic Areas expertise: antidiabetic agents, antihistamines, anti-infective/ anti-viral agents (antibacterial agents, Antibiotics, antimicotics, HIV, etc.), Immunosuppressive agents, Rheumatoid arthritis, Lupus, Psoriatic arthritis (traditional and biologic), Oncology products (traditional and biologic), Rare and orphan diseases (hemophilia, hereditary angioedema, Fabry, Gaucher, CLL, pulmonary hypertension, hereditary hyper-cholesterolemia, multiple scleroses, Pompe, etc.), Anticoagulants (platelet aggregation inhibitors, thrombolytic agents), Vaccines, Nuclear medicine, Contraceptives, Bronchodilators, Bone diseases, Cardiovascular drugs, Central nervous system drugs (Analgesics, Anticonvulsants, Antidepressants, Central nervous system depressants, Anxiolytics, Anti-maniac agents, Alzheimer products, Multiple scleroses, etc.), Corticoids, Dermatology products, Psoriasis, Gastrointestinal drugs, Hormones, Nutrotherapic products, Dietary supplements, Infant milk formulas, Ophthalmic, Pain management, Sexual dysfunction and Vitamins. EXPERIENCE IN MARKET ACCESS in Argentina, Brazil, Chile, Colombia and Mexico. OBSERVATIONAL STUDIES WITH IRB approval projects in Argentina, Brazil, Chile, Colombia and Mexico. COMPLIANCE AND QUALITY: Compliance is a serious matter at D&E. D&E complies with all national and international laws protecting personal data and with guidelines and all other relevant national and international codes of practice. Besides D&E complies with the fundamental principles to data processing: purpose, data accuracy, restrictions and confidentiality. D&E adheres to the codes of conduct / industry standards of ESOMAR, EphMRA, SAIMO. D&E has long lasting partnerships and referrals from satisfied clients generating most new business, our client loyalty proves we deliver what we promise.
D&E Research - Datos & Estrategias revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
D&E Research - Datos & Estrategias has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
D&E Research - Datos & Estrategias has never raised funding before.
D&E Research - Datos & Estrategias Tech Stack
Discover the technologies and tools that power D&E Research - Datos & Estrategias's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Frequently asked questions
4.8
40,000 users



